ロード中...
Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery()
BACKGROUND: New vaccines to prevent tuberculosis are urgently needed. MVA85A is a novel viral vector TB vaccine candidate designed to boost BCG-induced immunity when delivered intradermally. To date, intramuscular delivery has not been evaluated. Skin and muscle have distinct anatomical and immunolo...
保存先:
| 出版年: | Vaccine |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier Science
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5405058/ https://ncbi.nlm.nih.gov/pubmed/23266342 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2012.12.042 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|